Presentation for AusBiotech 2018
The annual AusBiotech conference brings together Australian and international biotech leaders and stakeholders. For more than three decades, the event has created a forum to reflect on the sector's achievements and exchange ideas to further advance the sector's standing both nationally and globally. AusBiotech is dedicated to consolidating this growth.
John Martin was invited to present as part of the Regenerative Medicine Stream. His session will focus on the successful translation and commercialisation of novel regenerative medicines by Australian companies. MTPConnect, the Australian Government's medtech and pharma growth centre, launched a report entitled 'Regenerative Medicine: Opportunities for Australia' at the beginning of the session. The report was produced in collaboration with AusBiotech's Regenerative Medicine Advisory Group, of which John Martin is a member, as well as other key stakeholders from industry and the research sector.
The following are specific details regarding Regeneus' presentation:
Event: AusBiotech 2018
Date: 31 October 2018
Time: 2.30pm (AEST)
Location: Room 2, Brisbane Convention and Exhibition Centre, Southbank, Brisbane
To view the presentation, please visit:
About Regeneus Ltd
Regeneus Ltd (ASX:RGS) is a Sydney-based clinical-stage regenerative medicine company using stem cell and immuno-oncology technologies to develop a portfolio of innovative cell-based therapies to address significant unmet medical needs in the human and animal health markets with a focus on osteoarthritis and other musculoskeletal disorders, oncology and dermatology.